Related Experiment Video
Updated: Jun 8, 2025

Determining Glucose Metabolism Kinetics Using 18F-FDG Micro-PET/CT
Published on: May 2, 2017
Multi-task Bayesian model combining FDG-PET/CT imaging and clinical data for interpretable high-grade prostate cancer
Maxence Larose1,2, Louis Archambault3,4, Nawar Touma5
1Département de physique, de génie physique et d'optique, et Centre de recherche sur le cancer, Université Laval, Québec, QC, Canada. maxence.larose.1@ulaval.ca.
A new Bayesian Sequential Network (BSN) model accurately predicts high-grade prostate cancer (PCa) prognosis using imaging and clinical data. This AI tool aids in identifying patients who may benefit from intensified treatment strategies.
Area of Science:
- Oncology
- Medical Imaging
- Artificial Intelligence
Background:
- Prostate cancer (PCa) prognosis prediction is crucial for treatment planning.
- Accurate prediction of high-grade PCa (Gleason ≥ 8) outcomes remains challenging.
- Current methods often lack integration of multi-modal data and dynamic prediction capabilities.
Purpose of the Study:
- To develop and validate a fully automatic multi-task Bayesian model (BSN) for predicting high-grade PCa prognosis.
- To leverage pre-prostatectomy FDG-PET/CT images and clinical data for enhanced predictive accuracy.
- To introduce novel features like automated segmentation, uncertainty quantification, and dynamic predictions.
Main Methods:
- Development of the Bayesian Sequential Network (BSN), a multi-task Bayesian model.
- Integration of FDG-PET/CT imaging and clinical data for 295 patients.
- Implementation of classification and multiple survival prediction tasks (e.g., lymph node invasion, recurrence-free survival).
Main Results:
- BSN demonstrated superior performance compared to traditional nomograms across most prognostic tasks.
- The model successfully performed automated prostate segmentation and provided uncertainty quantification.
- Dynamic predictions, refining long-term prognosis using short-term outcomes, were introduced.
Conclusions:
- The BSN model shows significant promise for improving prognostic accuracy in high-grade prostate cancer.
- It effectively utilizes multi-modal data, including imaging, for personalized risk stratification.
- BSN can aid in identifying patients requiring treatment intensification, optimizing therapeutic strategies.
More Related Videos
09:03Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET
Published on: October 22, 2019
07:15Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020